Blood lipid profile and prevalence of dyslipidemia in Chinese adults.
- Author:
Wen-Hua ZHAO
1
;
Jian ZHANG
;
Yi ZHAI
;
Yue YOU
;
Qing-Qing MAN
;
Chun-Rong WANG
;
Hong LI
;
Ying LI
;
Xiao-Guang YANG
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; China; epidemiology; Dyslipidemias; blood; epidemiology; Female; Humans; Lipids; blood; classification; Male; Middle Aged; Prevalence
- From: Biomedical and Environmental Sciences 2007;20(4):329-335
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo investigate the plasma lipid levels in a national representative sample of subjects and to determine the prevalence of dyslipidemia in the Chinese population.
METHODSPlasma lipid profile was analyzed using the data obtained during the Chinese national nutrition and health survey (CNHS) in 2002 which involved 14 252 participants at the age of 18 years or older.
RESULTSThe mean levels of total cholesterol (TC), triglyceride (TG) and high density lipoprotein cholesterol (HDL-C) in the participants were 3.81 mmol/L, 1.10 mmol/L, and 1.30 mmol/L, respectively. In the groups of participants at the age of 18-44 years, 45-59 years, and over 60 years the mean TC level was 3.70 mmol/L, 4.09 mmol/L and 4.21 mmol/L, respectively, and the mean TG level was 07 mmol/L, 1.21 mmol/L, 1.20 mmol/L, 1.29 mmol/L, 1.33 mmol/L, and 1.33 mmol/L, respectively. The prevalence of dyslipidemia in Chinese adults was 18.6% and 22.2% in males and 15.9% in females. Dyslipidemia prevalence was higher in urban districts than in rural areas (21.0% vs. 17.7%). The prevalence of hypercholesterolemia, hypertriglyceridemia, and low HDL cholesterol was 2.9%, 11.9%, and 7.4% respectively among the participants.
CONCLUSIONDyslipidemia has become one of the important health risk factors in the Chinese population. There is no significantly difference in the prevalence of dyslipidemia between the groups of participants at the age of 45-59 years and over 60 years. This study provides important lipid profile data for policy making and guideline development for the prevention of dyslipidemia in the Chinese population.